NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line

Journal of Leukocyte Biology

Volumn 60, Issue 2, 1996, Pages 245-252

  Mateo, Romeo B ^a   Reichner, Jonathan S ^a   Albina, Jorge E ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Cytotoxicity; Macrophage; Nitric oxide; P815

Indexed keywords

NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL LINE;

EID: 0029740961     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.2.245     Document Type: Article

References (37)

1. Adams, D.O., Johnson, W.J., Marino, P.A. (1982). Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity. Fed. Proc. 41, 2212-2221.
2. Keller, R., Geiges, M., Keist, R. (1990). L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res. 50, 1421-1425.
3. Hibbs, J.B., Jr., Vavrin, Z., Taintor, R.R. (1987). L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J.Immunol. 138, 550-565.
4. Nathan, C.F., Brukner, L.H., Silverstein, S.C., Cohn, Z.A. (1979). Extracellular cytolysis by activated macrophages and granulocytes: I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp.Med. 149, 84-99.
5. Adams, D.O., Nathan, C.F. (1983). Molecular mechanisms in tumor-cell killing by activated macrophages. Immunol. Today 4, 166-170.
6. Prpic, V., Weiel, J.E., Somers, S.D., DiGuiseppi, J., Gonias, S.L., Pizzo, S.V., Hamilton, T.A., Herman, B., Adams, D.O. (1987). Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-biphosphate in murine peritoneal macrophages. J.Immunol. 139, 526-533.
7. Klostergaard, J., Leroux, M.E., Hung, M.-C. (1991). Cellular models of macrophage tumoricidal effector mechanisms in vitro: Characterization of cytolylic responses to tumor necrosis factor and nitric oxide pathways in vitro. J. Immunol. 147, 2802-2808.
8. Higuchi, M., Higashi, N., Taki, H., Osawa, T. (1990). Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144, 1425-1431.
9. Keller, R., Keist, R. (1989). Abilities of activated macrophages to manifest tumoricidal activity and to generate reactive nitrogen intermediates: a comparative study in vitro and ex vivo. Biochem. Biophys. Res. Commun. 164, 968-973.
10. Albina, J.E., Mills, C.D., Henry, W.L., Jr., Caldwell, M.D. (1989). Regulation of macrophage physiology by L-arginine: role of the oxidalive L-arginine deiminase pathway. J. Immunol. 143, 3641-3646.
11. Albina, J.E., Caldwell, M.D., Henry, W.L., Jr., Mills, C.D. (1989). Regulation of macrophage functions by L-arginine. J. Exp. Med. 169, 1021-1029.
12. Albina, J.E., Cui, S., Mateo, R.B., Reichner, J.S. (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150, 5080-5085.
13. Klostergaard, J., Leroux, M.E. (1989). L-Arginine independent macrophage tumor cytotoxicity. Biochem. Biophys. Res. Commun. 165, 1262-1266.
14. Albina, J.E., Mills, C.D., Barbul, A., Thirkill, C.E., Henry, W.L., Jr., Mastrofrancesco, B., Caldwell, M.D. (1988). Arginine metabolism in wounds. Am. J. Physiol. 254, E459-E467.
15. Albina, J.E., Mills, C.D., Henry, W.L., Jr., Caldwell, M.D. (1990). Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144, 3877-3880.
16. Bodenheimer, H.C., Faris, R.A., Charland, C., Hixson, D.C. (1988). Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells. Hepatology 8, 1667-1672.
17. Nathan, C.F., Arrick, B.A., Murray, H.W., DeSantis, N.M., Cohn, Z.A. (1980). Tumor cell anti-oxidant defenses: inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J. Exp. Med. 153, 766-782.
18. Rabinovitch, M., DeStefano, M.J. (1973). Macrophage spreading in vitro. Exp. Cell Res. 77, 323-334.
19. Ding, A.H., Nathan, C.F., Stuehr, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
20. Albina, J.E., Henry, W.L., Jr. (1991). Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50, 403-409.
21. Albina, J.E., Abate, J.A., Henry, W.L., Jr. (1991). Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. J. Immunol. 147, 144-148.
22. Cui, S., Reichner, J.S., Mateo, R.B., Albina, J.E. (1994). Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467.
23. Marino, P.A., Adams, D.O. (1980). Interaction of bacillus Calmette-Guérin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity. Cell. Immunol. 54, 11-25.
24. Marino, P.A., Adams, D.O. (1980). Interaction of bacillus Calmette-Guérin-activated macrophages and neoplastic cells in vitro. II. The relationship of selective binding to cytolysis. Cell. Immunol. 54, 26-35.
25. Marino, P.A., Whisnant, C.C., Adams, D.O. (1981). Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells. J. Exp. Med. 154, 77-87.
26. Keller, R., Keist, R., Groseurth, P. (1986). Firm persistent binding between activated macrophages and tumor cells is not a prerequisite for the mediation of cytolysis. Br. J. Cancer 37, 89-95.
27. Drapier, J.-C., Hibbs, J.B., Jr. (1988). Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140, 2829-2838.
28. Hibbs, J.B., Jr., Taintor, R.R., Vavrin, Z. (1987). Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235, 473-476.
29. Albina, J.E., Mastrofrancesco, B. (1993). Modulation of glucose metabolism in macrophages by products of nitric oxide synthase. Am. J. Physiol. 264, C1594-C1599.
30. Jorens, P.G., Van Overeld, F.J., Bult, H., Vermeire, P.A., Herman, A.G. (1992). Serine-protease inbibitors modulate nitric oxide-synthase activity of alveolar macrophages. Agents Actions 36, 243-247.
31. Pryor, W.A., Squadrito, G.L. (1995). The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am.J.Physiol. 268, L699-L722.
32. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
33. Radi, R., Beekman, J.S., Bush, K.M., Freeman, B.A. (1991). Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J.Biol.Chem. 266, 4244-4250.
34. Ischiropoulos, H., Zhu, L., Beckman, J.S. (1992). Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298, 446-451.
35. Beckman, J.S., Crow, J.P. (1993). Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21, 330-334.
36. Grisham, M.B. (1995). Interaction between nitric oxide and superoxide: role in modulating leukocyte adhesion in the postischemic microvasculature. Transplant. Proc. 27, 2842-2843.
37. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotocicity by macrophages. Cell 80, 353-361.